Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1187 studies found for:    glioblastoma
Show Display Options
Rank Status Study
21 Recruiting Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
Condition: Adult Glioblastoma
Interventions: Radiation: Radiation;   Device: 3 Tesla magnetic resonance imaging;   Device: Chemical exchange saturation transfer MRI;   Device: Diffusion weighted MRI;   Device: Dynamic contrast enhancement MRI;   Device: Dynamic susceptibility contrast MRI
22 Active, not recruiting Amgen 386 for Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: Amgen 386;   Drug: Bevacizumab
23 Recruiting Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention:
24 Completed A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
Condition: Recurrent Glioblastoma
Intervention: Drug: PLX3397
25 Completed Enzastaurin Versus Lomustine in Glioblastoma
Condition: Glioblastoma
Interventions: Drug: enzastaurin;   Drug: lomustine
26 Recruiting INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Condition: Glioblastoma
Interventions: Drug: Temozolomide;   Drug: Neratinib;   Drug: CC-115;   Drug: Abemaciclib
27 Completed
Has Results
A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: MEDI-575
28 Recruiting FMISO PET Study of Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Device: FMISO PET;   Device: MRI;   Drug: Bevacizumab;   Drug: CCNU
29 Completed Neoadjuvant Nivolumab in Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: Nivolumab
30 Completed A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Radiation: Hypofractionated Intensity-Modulated Radiation Therapy;   Drug: Temozolomide
31 Completed Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
Condition: Glioblastoma
Interventions: Drug: Temozolomide;   Radiation: Radiation Therapy
32 Completed APG101 in Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: APG101;   Procedure: Blood drawing
33 Withdrawn Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
Condition: Glioblastoma Multiforme
Intervention: Drug: IL-4PE
34 Active, not recruiting Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
Condition: Glioblastoma
Intervention: Other: Observational study, no intervention
35 Completed
Has Results
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
Condition: Glioblastoma
Interventions: Procedure: Primary surgical treatment;   Radiation: Radiotherapy;   Drug: Temozolomide
36 Completed
Has Results
Ketogenic Diet for Recurrent Glioblastoma
Condition: Recurrent Glioblastoma
Intervention: Dietary Supplement: TAVARLIN
37 Completed Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
Condition: Glioblastoma
Intervention: Drug: Activated T lymphocyte(Immuncell-LC)
38 Terminated Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Drug: Phase 1 Dose Escalation;   Drug: Phase 1b;   Drug: Ancillary Study
39 Recruiting Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
Condition: Glioblastoma
Interventions: Biological: ALECSAT;   Radiation: radiotherapy;   Drug: Temozolomide
40 Recruiting Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Biological: anti-EGFRvIII CAR T cells;   Drug: cyclophosphamide;   Drug: Fludarabine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.